Apriso(Mesalamine Extended-Release Capsules)
APRISO Rx
Generic Name and Formulations:
Mesalamine 0.375g; ext-rel caps; contains phenylalanine 0.56mg/cap.
Company:
Valeant Pharmaceuticals, Inc
Indications for APRISO:
Maintenance of remission of ulcerative colitis (UC) in adults.
Adult:

≥18yrs: 1.5g once daily in the AM.

Children:

<18yrs: not recommended.

Warnings/Precautions:

Sulfasalazine allergy. Renal dysfunction or history of renal disease; assess renal function at the beginning and periodically during treatment. Hepatic impairment. Elderly (monitor CBCs). Pregnancy (Cat.B). Nursing mothers.

Interactions:

Do not co-administer with antacids.

Pharmacological Class:

Aminosalicylate.

Adverse Reactions:

Headache, GI upset, upper abdominal pain, nasopharyngitis, flu-like symptoms, sinusitis; renal impairment, mesalamine-induced acute intolerance syndrome (eg, cramping, abdominal pain, bloody diarrhea, fever, headache, rash); discontinue if occurs.

Generic Availability:

NO

How Supplied:

Caps—120